Search results for:
fluticasone-umeclidinium-vilanterol
fluticasone-umeclidinium-vilanterol
- Non-formulary
- Therapeutic Interchange
Drug Name |
Form |
Strength |
Formulary Unrestricted |
Formulary Restricted |
Non-Formulary |
Interchange |
Trelegy Ellipta |
POWDER, INHALATION |
100 mcg-62.5 mcg-25 mcg/act, 200 mcg-62.5 mcg-25 mcg/act |
|
|
|
|
Last updated: Apr. 11, 2024
Due to national shortage of the nebulization solutions, the formulary status of inhaler products has been temporarily adjusted to formulary, restricted to use during the albuterol/Duoneb shortage. Upon shortage resolution, these products will automatically return to their original formulary status. See Albuterol/Duoneb Shortage Mitigation for more information. (Updated Feb 2023)
fluticasone-umeclidinium-vilanterol (Trelegy Ellipta)
100 mcg-62.5 mcg-25 mcg/1 actuation once daily
Trelegy Ellipta medication guide
Inpatient may use own inhaler.
Reviewed: 25 June 19 (Trelegy Ellipta)
Updated: February 24 (Trelegy Ellipta Interchange)
Fluticasone umeclidinium vilanterol (Trelegy Ellipta)